First Trust Nasdaq Pharmaceuticals ETF (FTXH) Dividend Yield, History & Forecast

First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. It pays a current dividend yield of 1.09% ($0.42 per share annually (TTM)). The most recent ex-dividend date was June 25, 2026, with payment scheduled for June 30, 2026. market capitalization is approximately $37M.

Loading quote...

FTXH fund composition

FTXH holds 51 positions, with 0.0% of assets in its ten largest. It charges an expense ratio of 0.60%, and manages $912.2M.

Top 10 holdings

HoldingWeight
JNJJohnson & Johnson0.00%
TVTXTravere Therapeutics, Inc.0.00%
ELANElanco Animal Health Incorporated0.00%
TWSTTwist Bioscience Corporation0.00%
TXG10X Genomics, Inc. (Class A)0.00%
SYRESpyre Therapeutics, Inc.0.00%
PTCTPTC Therapeutics, Inc.0.00%
BMRNBioMarin Pharmaceutical Inc.0.00%
ALKSAlkermes Plc0.00%
HALOHalozyme Therapeutics, Inc.0.00%

Sector allocation

Healthcare100.0%

Frequently Asked Questions about First Trust Nasdaq Pharmaceuticals ETF (FTXH)

What is First Trust Nasdaq Pharmaceuticals ETF's dividend yield?
First Trust Nasdaq Pharmaceuticals ETF (FTXH) pays a current trailing twelve-month dividend yield of 1.09%, which works out to $0.42 per share annually based on the most recent payout schedule.
When does First Trust Nasdaq Pharmaceuticals ETF pay its next dividend?
The most recent ex-dividend date was June 25, 2026. The next scheduled dividend payment date is June 30, 2026.
How many years has First Trust Nasdaq Pharmaceuticals ETF increased its dividend?
First Trust Nasdaq Pharmaceuticals ETF (FTXH) has increased its dividend for 8 consecutive years.
Is First Trust Nasdaq Pharmaceuticals ETF a Dividend Aristocrat?
No. Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. First Trust Nasdaq Pharmaceuticals ETF (FTXH) currently has 8 years of consecutive increases.
What sector is First Trust Nasdaq Pharmaceuticals ETF in?
First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates in the Financial Services sector, specifically the Asset Management - Global industry.